A specialist team that turns complex biomedical data into decision-ready evidence
We work with translational and clinical teams to analyse multi-modal datasets, explain treatment response, and deliver reproducible evidence that supports the decisions that matter.
Why Sonrai Exists
Biomedical data has become too complex for teams to integrate, interpret, and act on consistently. Clinical, molecular, and imaging datasets are often disconnected, making it difficult to generate insights that hold up across programs and lead to confident decisions.
We work alongside translational and clinical teams to connect this data, uncover the biological drivers of response, and deliver the evidence needed to move programs forward.
Most teams aren't short of data. They're short of decisions. We built Sonrai so that every analysis we deliver moves a program forward, not just adds to the pile.
Built from real translational challenges
Founded by bioinformatics and translational research experts who experienced first-hand how difficult it was to move from data to decision. We built Sonrai to change that.
Founded on a translational research problem
Queens University Belfast bioinformatics researchers build Sonrai to close the gap between complex biomedical data and the decisions it should support.
First commercial biotech partnership
Sonrai delivers its first commercial analysis, validating the approach with real program data.
Roche ACTIONED consortium ($7M programme)
Selected to join a major multi-partner consortium with Roche — one of the largest multi-omic clinical trial analysis programmes of its kind.
Institutional investment to build the platform
First VC funding secured to develop the infrastructure for reproducible, governed analysis at scale.
NIHR award: government-funded AI diagnostics research (£2.2M)
National Institute for Health Research funding validates Sonrai's approach to AI-assisted biomarker analysis.
Sonrai Discovery platform launches
The Sonrai Discovery environment goes live — a secure, reproducible Trusted Research Environment built for multi-modal biomedical analysis.
Secure data governance, reproducible workflows, and traceable outputs across target ID, translational analytics, and patient stratification.
Second funding round secured
Further investment to grow the team and expand analytical capabilities across oncology and precision medicine.
Client base triples. New HQ at Titanic Quarter, Belfast
Significant growth in global demand. Sonrai moves to larger headquarters to support an expanding team and programme portfolio.
Why teams choose Sonrai
We work with translational and clinical teams to solve complex data challenges and deliver evidence that directly informs program decisions.
Our bioinformaticians and translational scientists design, run, and interpret every analysis. You get expert judgement, not just outputs.
We combine clinical, molecular, imaging, and public datasets to generate a complete, biologically grounded view of response and resistance.
Every analysis is governed, documented, and repeatable. Our outputs can be reviewed, trusted, and built on across teams and programs.
We deliver outputs built to support target selection, patient stratification, biomarker strategy, and clinical direction — not just data summaries.
Built on a secure, reproducible foundation
All work is delivered within Sonrai's Trusted Research Environment (TRE), ensuring that insights are not only accurate, but reliable and defensible in real-world decision-making.
This is not just a technical requirement. It is what allows our clients to trust the analysis, repeat the process, and present the evidence with confidence.
All data is accessed and processed within a controlled, auditable environment — ensuring security and compliance throughout every engagement.
Every analysis is structured so it can be repeated, reviewed, and validated — giving teams the confidence to build on findings across programs.
Every step of the analysis is documented and traceable — from raw data to final evidence — supporting internal reviews and external discussions.
Internal and external teams can collaborate within a governed environment — maintaining data integrity and consistency across the program.
A multidisciplinary team supporting translational programs
Bioinformaticians, data scientists, and translational experts working across oncology and precision medicine to support organisations globally.
Designing and executing multi-modal analyses that connect molecular signals to biological meaning.
Integrating, structuring, and modelling complex biomedical datasets to generate reproducible, trustworthy outputs.
Connecting preclinical and clinical evidence to support program decisions across the development lifecycle.
Discuss your data and decisions
If you're working with complex biomedical data and need clear, reproducible evidence, we can help. We define the right questions, integrate the data, and deliver insights that support confident program decisions.
Talk to our teamWhat to expect
We discuss your program, your data, and the decisions you need to support.
We outline how we would structure the analysis to answer the right questions.
Clear, reproducible outputs your team can act on with confidence.